AstraZeneca Gets Exclusive Japan Rights For Dapagliflozin From BMS, To Co-Promote With Ono

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia